Genocea Biosciences (GNCAQ)
OTHER OTC:GNCAQ
Holding GNCAQ?
Track your performance easily

Genocea Biosciences (GNCAQ) Income Statement

738 Followers

Genocea Biosciences Income Statement

Last quarter (Q ), Genocea Biosciences's total revenue was $270.00K, a decrease of -32.50% from the same quarter last year. In Q, Genocea Biosciences's net income was $-15.98M. See Genocea Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ 1.51M$ 1.64M$ 1.36M---
Cost of Revenue
------
Gross Profit
$ 1.51M$ 1.64M$ 1.36M---
Operating Expense
$ 57.35M$ 53.73M$ 48.35M$ -38.99M$ -39.52M$ -55.26M
Operating Income
$ -55.48M$ -52.10M$ -46.99M$ -38.99M$ -39.52M$ -52.64M
Net Non Operating Interest Income Expense
$ -1.07M$ -1.12M$ -1.38M$ -946.00K$ -1.02M$ -1.44M
Other Income Expense
$ -19.09M$ -20.02M$ -4.66M$ -985.00K$ -12.73M$ 14.00K
Pretax Income
$ -37.19M$ -33.20M$ -43.71M$ -38.95M$ -27.81M$ -56.71M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -37.19M$ -33.20M$ -43.71M$ -38.95M$ -27.81M$ -56.71M
Basic EPS
$ -0.52$ -0.48$ -0.98---
Diluted EPS
$ -0.69$ -0.48$ -1.11$ -1.89$ -2.72$ -15.84
Basic Average Shares
$ 279.26M$ 68.58M$ 44.44M$ 20.64M$ 10.32M$ 3.58M
Diluted Average Shares
$ 271.20M$ 68.58M$ 46.55M$ 20.64M$ 10.22M$ 3.58M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 57.35M$ 53.73M$ 48.35M$ -38.99M$ -39.52M$ -55.26M
Net Income From Continuing And Discontinued Operation
$ -37.19M$ -33.20M$ -43.71M$ -38.95M$ -27.81M$ -56.71M
Normalized Income
$ -29.38M$ -26.22M----
Interest Expense
------
EBIT
$ -36.12M$ -32.08M$ -42.33M$ -38.00M$ -26.79M$ -55.27M
EBITDA
$ -34.04M$ -30.01M$ -40.74M$ -36.91M$ -25.70M$ -53.75M
Currency in USD

Genocea Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis